Schulhoff & Co Inc
- SEC CIK
- 0001080197
- Latest filing
- Aug 13, 2026
AVDL holding history
Avadel Pharmaceuticals PLC in every 13F filed by Schulhoff & Co Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −137,500−100.0% | Sold out | Holders |
| Q3 2025 | 137,500 | $2.10M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2025 | 137,500 | $1.22M | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2025 | 137,500 | $1.08M | 0.5% | +500+0.4% | Added | Holders |
| Q4 2024 | 137,000 | $1.44M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2024 | 137,000 | $1.80M | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2024 | 137,000 | $1.93M | 0.9% | 00.0% | Unchanged | Holders |
| Q1 2024 | 137,000 | $2.31M | 1.0% | +41,000+42.7% | Added | Holders |
| Q4 2023 | 96,000 | $1.36M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2023 | 96,000 | $988.8K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2023 | 96,000 | $1.58M | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2023 | 96,000 | $879.4K | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2022 | 96,000 | $687.4K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2022 | 96,000 | $480.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2022 | 96,000 | $234.0K | 0.1% | +35,000+57.4% | Added | Holders |
| Q1 2022 | 61,000 | $416.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2021 | 61,000 | $492.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 61,000 | $597.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2021 | 61,000 | $410.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2021 | 61,000 | $551.0K | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.